PHLDA1 and neuroblastoma: Additionally, considering that PHLDA1 has been shown with significant activation upon anti-GD2 treatment in NB patients [89], Bugara et al. conducted a study on GD2 therapy in NB utilizing transcriptomic and proteomic analyses of IMR-32 cells.